Diminishing Value from Multiple Serial Bone Densitometry in Women Receiving Antiresorptive Medication for Osteoporosis.

Gregory A KlineSuzanne N MorinSidney FeldmanLisa M LixWilliam D Leslie

Published in: The Journal of clinical endocrinology and metabolism (2021)

Among women highly adherent to antiresorptive therapy for osteoporosis, a very small percentage sustained BMD losses on repeated measures. The value of multiple serial BMD monitoring to detect persistent suboptimal responders should be questioned.

Keyphrases

bone mineral density
polycystic ovary syndrome
postmenopausal women
pregnancy outcomes
cervical cancer screening
healthcare
body composition
breast cancer risk
type diabetes
pregnant women
insulin resistance
metabolic syndrome
skeletal muscle
adverse drug